Precision Optics Corporation, Inc. (POCI)
USD 4.24
(3.16%)
USD 4.24
(3.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 16.91 Million USD | -14.33% |
| 2023 | 19.74 Million USD | 18.18% |
| 2022 | 16.7 Million USD | 166.78% |
| 2021 | 6.26 Million USD | -1.42% |
| 2020 | 6.35 Million USD | -15.24% |
| 2019 | 7.49 Million USD | 198.36% |
| 2018 | 2.51 Million USD | 39.47% |
| 2017 | 1.8 Million USD | -15.18% |
| 2016 | 2.12 Million USD | 3.98% |
| 2015 | 2.04 Million USD | 11.19% |
| 2014 | 1.83 Million USD | -20.26% |
| 2013 | 2.3 Million USD | 84.78% |
| 2012 | 1.24 Million USD | 11.01% |
| 2011 | 1.12 Million USD | -41.78% |
| 2010 | 1.92 Million USD | -2.35% |
| 2009 | 1.97 Million USD | -13.43% |
| 2008 | 2.28 Million USD | -24.84% |
| 2007 | 3.03 Million USD | -5.98% |
| 2006 | 3.22 Million USD | -4.16% |
| 2005 | 3.36 Million USD | 60.62% |
| 2004 | 2.09 Million USD | -63.36% |
| 2003 | 5.72 Million USD | -35.55% |
| 2002 | 8.88 Million USD | -53.8% |
| 2001 | 19.22 Million USD | -4.31% |
| 2000 | 20.08 Million USD | 508.64% |
| 1999 | 3.3 Million USD | -35.29% |
| 1998 | 5.1 Million USD | -15.0% |
| 1997 | 6 Million USD | -15.49% |
| 1996 | 7.1 Million USD | 16.39% |
| 1995 | 6.1 Million USD | 17.31% |
| 1994 | 5.2 Million USD | 1.96% |
| 1993 | 5.1 Million USD | -15.0% |
| 1992 | 6 Million USD | 93.55% |
| 1991 | 3.1 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 19.06 Million USD | -3.4% |
| 2024 Q3 | 18.27 Million USD | 3.25% |
| 2024 Q2 | 17.69 Million USD | -7.19% |
| 2024 Q4 | 16.91 Million USD | -7.44% |
| 2023 Q2 | 17.46 Million USD | 1.76% |
| 2023 Q1 | 17.16 Million USD | 2.78% |
| 2023 FY | 19.74 Million USD | 18.18% |
| 2023 Q3 | 18.18 Million USD | 4.11% |
| 2023 Q4 | 19.74 Million USD | 8.54% |
| 2022 Q3 | 17.26 Million USD | 2.24% |
| 2022 FY | 16.7 Million USD | 166.78% |
| 2022 Q1 | 7.1 Million USD | 13.43% |
| 2022 Q2 | 16.88 Million USD | 137.81% |
| 2022 Q4 | 16.7 Million USD | -3.26% |
| 2021 Q3 | 5.9 Million USD | 0.73% |
| 2021 Q4 | 6.26 Million USD | 6.02% |
| 2021 FY | 6.26 Million USD | -1.42% |
| 2021 Q1 | 6.13 Million USD | -3.46% |
| 2021 Q2 | 5.86 Million USD | -4.38% |
| 2020 FY | 6.35 Million USD | -15.24% |
| 2020 Q1 | 6.03 Million USD | -19.43% |
| 2020 Q2 | 5.78 Million USD | -4.23% |
| 2020 Q3 | 5.84 Million USD | 1.14% |
| 2020 Q4 | 6.35 Million USD | 8.62% |
| 2019 FY | 7.49 Million USD | 198.36% |
| 2019 Q4 | 7.49 Million USD | 106.06% |
| 2019 Q1 | 2.31 Million USD | -7.98% |
| 2019 Q2 | 3.86 Million USD | 67.12% |
| 2019 Q3 | 3.63 Million USD | -5.85% |
| 2018 Q4 | 2.51 Million USD | 20.06% |
| 2018 FY | 2.51 Million USD | 39.47% |
| 2018 Q1 | 1.92 Million USD | 6.68% |
| 2018 Q2 | 2.3 Million USD | 19.99% |
| 2018 Q3 | 2.09 Million USD | -9.24% |
| 2017 Q3 | 2.02 Million USD | -10.56% |
| 2017 Q2 | 2.26 Million USD | 16.87% |
| 2017 FY | 1.8 Million USD | -15.18% |
| 2017 Q1 | 1.94 Million USD | -8.62% |
| 2017 Q4 | 1.8 Million USD | -11.2% |
| 2016 Q3 | 2.04 Million USD | -2.3% |
| 2016 Q1 | 1.72 Million USD | -15.66% |
| 2016 Q4 | 2.12 Million USD | 3.96% |
| 2016 FY | 2.12 Million USD | 3.98% |
| 2016 Q2 | 2.09 Million USD | 21.38% |
| 2015 Q1 | 2.24 Million USD | 22.21% |
| 2015 Q4 | 2.04 Million USD | -8.17% |
| 2015 Q3 | 2.22 Million USD | -10.49% |
| 2015 FY | 2.04 Million USD | 11.19% |
| 2015 Q2 | 2.48 Million USD | 10.69% |
| 2014 Q3 | 1.89 Million USD | -3.89% |
| 2014 Q4 | 1.83 Million USD | -3.07% |
| 2014 FY | 1.83 Million USD | -20.26% |
| 2014 Q2 | 1.97 Million USD | -9.4% |
| 2014 Q1 | 2.17 Million USD | -5.53% |
| 2013 Q2 | 2.67 Million USD | -20.89% |
| 2013 FY | 2.3 Million USD | 84.78% |
| 2013 Q4 | 2.3 Million USD | -8.12% |
| 2013 Q3 | 2.5 Million USD | -6.37% |
| 2013 Q1 | 3.38 Million USD | 171.53% |
| 2012 Q1 | 2.82 Million USD | 151.41% |
| 2012 Q3 | 1.33 Million USD | -19.91% |
| 2012 Q2 | 1.67 Million USD | -40.75% |
| 2012 FY | 1.24 Million USD | 11.01% |
| 2012 Q4 | 1.24 Million USD | -6.96% |
| 2011 FY | 1.12 Million USD | -41.78% |
| 2011 Q2 | 1.33 Million USD | -22.26% |
| 2011 Q1 | 1.72 Million USD | -10.78% |
| 2011 Q3 | 1.33 Million USD | -0.4% |
| 2011 Q4 | 1.12 Million USD | -15.73% |
| 2010 Q3 | 1.93 Million USD | 7.89% |
| 2010 FY | 1.92 Million USD | -2.35% |
| 2010 Q4 | 1.92 Million USD | -0.12% |
| 2010 Q2 | 1.78 Million USD | -1.49% |
| 2010 Q1 | 1.81 Million USD | -8.02% |
| 2009 Q4 | 1.97 Million USD | -2.54% |
| 2009 FY | 1.97 Million USD | -13.43% |
| 2009 Q2 | 2.03 Million USD | 1.85% |
| 2009 Q3 | 2.02 Million USD | -0.32% |
| 2009 Q1 | 1.99 Million USD | -12.5% |
| 2008 Q2 | 1.75 Million USD | -26.52% |
| 2008 Q3 | 1.72 Million USD | -1.67% |
| 2008 Q4 | 2.28 Million USD | 32.25% |
| 2008 Q1 | 2.38 Million USD | -21.34% |
| 2008 FY | 2.28 Million USD | -24.84% |
| 2007 Q3 | 3.83 Million USD | 100.53% |
| 2007 Q4 | 3.03 Million USD | -20.76% |
| 2007 FY | 3.03 Million USD | -5.98% |
| 2007 Q1 | 2.54 Million USD | -21.33% |
| 2007 Q2 | 1.91 Million USD | -24.79% |
| 2006 Q4 | 3.22 Million USD | 76.36% |
| 2006 Q2 | 2.13 Million USD | -25.37% |
| 2006 Q1 | 2.86 Million USD | -15.04% |
| 2006 FY | 3.22 Million USD | -4.16% |
| 2006 Q3 | 1.83 Million USD | -14.3% |
| 2005 FY | 3.36 Million USD | 60.62% |
| 2005 Q1 | 6.24 Million USD | 197.62% |
| 2005 Q3 | 4.47 Million USD | -15.92% |
| 2005 Q4 | 3.36 Million USD | -24.79% |
| 2005 Q2 | 5.32 Million USD | -14.67% |
| 2004 Q1 | 5.29 Million USD | -7.42% |
| 2004 FY | 2.09 Million USD | -63.36% |
| 2004 Q4 | 2.09 Million USD | -29.4% |
| 2004 Q3 | 2.97 Million USD | -24.6% |
| 2004 Q2 | 3.93 Million USD | -25.65% |
| 2003 FY | 5.72 Million USD | -35.55% |
| 2003 Q4 | 5.72 Million USD | -15.67% |
| 2003 Q3 | 6.78 Million USD | -5.19% |
| 2003 Q2 | 7.15 Million USD | -13.67% |
| 2003 Q1 | 8.29 Million USD | -6.62% |
| 2002 FY | 8.88 Million USD | -53.8% |
| 2002 Q4 | 8.88 Million USD | -15.3% |
| 2002 Q3 | 10.48 Million USD | -9.89% |
| 2002 Q2 | 11.63 Million USD | -12.24% |
| 2002 Q1 | 13.25 Million USD | -31.02% |
| 2001 Q2 | 21.19 Million USD | -4.33% |
| 2001 Q4 | 19.22 Million USD | -5.01% |
| 2001 FY | 19.22 Million USD | -4.31% |
| 2001 Q1 | 22.14 Million USD | 10.28% |
| 2001 Q3 | 20.23 Million USD | -4.52% |
| 2000 Q2 | 4.4 Million USD | 10.0% |
| 2000 FY | 20.08 Million USD | 508.64% |
| 2000 Q3 | 20.09 Million USD | 356.69% |
| 2000 Q1 | 4 Million USD | 21.21% |
| 2000 Q4 | 20.08 Million USD | -0.05% |
| 1999 Q4 | 3.3 Million USD | -15.38% |
| 1999 FY | 3.3 Million USD | -35.29% |
| 1999 Q1 | 4.5 Million USD | -11.76% |
| 1999 Q2 | 4.2 Million USD | -6.67% |
| 1999 Q3 | 3.9 Million USD | -7.14% |
| 1998 Q1 | 5.6 Million USD | -6.67% |
| 1998 Q4 | 5.1 Million USD | 6.25% |
| 1998 Q3 | 4.8 Million USD | -7.69% |
| 1998 Q2 | 5.2 Million USD | -7.14% |
| 1998 FY | 5.1 Million USD | -15.0% |
| 1997 Q2 | 6.8 Million USD | -2.86% |
| 1997 Q4 | 6 Million USD | -7.69% |
| 1997 FY | 6 Million USD | -15.49% |
| 1997 Q1 | 7 Million USD | -1.41% |
| 1997 Q3 | 6.5 Million USD | -4.41% |
| 1996 FY | 7.1 Million USD | 16.39% |
| 1996 Q3 | 6.7 Million USD | 6.35% |
| 1996 Q1 | 6.1 Million USD | 0.0% |
| 1996 Q2 | 6.3 Million USD | 3.28% |
| 1996 Q4 | 7.1 Million USD | 5.97% |
| 1995 Q3 | 5.5 Million USD | 7.84% |
| 1995 Q4 | 6.1 Million USD | 10.91% |
| 1995 Q2 | 5.1 Million USD | 2.0% |
| 1995 Q1 | 5 Million USD | -3.85% |
| 1995 FY | 6.1 Million USD | 17.31% |
| 1994 Q2 | 4.9 Million USD | 0.0% |
| 1994 Q3 | 5 Million USD | 2.04% |
| 1994 Q4 | 5.2 Million USD | 4.0% |
| 1994 FY | 5.2 Million USD | 1.96% |
| 1994 Q1 | 4.9 Million USD | -3.92% |
| 1993 Q3 | 5.4 Million USD | -5.26% |
| 1993 Q2 | 5.7 Million USD | 1.79% |
| 1993 Q1 | 5.6 Million USD | -6.67% |
| 1993 FY | 5.1 Million USD | -15.0% |
| 1993 Q4 | 5.1 Million USD | -5.56% |
| 1992 FY | 6 Million USD | 93.55% |
| 1992 Q4 | 6 Million USD | 0.0% |
| 1991 FY | 3.1 Million USD | 0.0% |
| 1991 Q4 | 3.1 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 90.623% |
| AngioDynamics, Inc. | 317.67 Million USD | 94.676% |
| AtriCure, Inc. | 613.93 Million USD | 97.245% |
| Avinger, Inc. | 13.77 Million USD | -22.822% |
| Azenta, Inc. | 2.88 Billion USD | 99.414% |
| BioLife Solutions, Inc. | 412.71 Million USD | 95.902% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.855% |
| Daxor Corporation | 34.86 Million USD | 51.497% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | 41.515% |
| Femasys Inc. | 27.75 Million USD | 39.067% |
| GlucoTrack, Inc. | 4.9 Million USD | -244.803% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 87.688% |
| Hologic, Inc. | 9.15 Billion USD | 99.815% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.614% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.89% |
| KORU Medical Systems, Inc. | 28.46 Million USD | 40.576% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 95.123% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -171.96% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -171.96% |
| Masimo Corporation | 3.04 Billion USD | 99.444% |
| Microbot Medical Inc. | 8.32 Million USD | -103.105% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 90.162% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 99.273% |
| Nephros, Inc. | 11.86 Million USD | -42.59% |
| NovoCure Limited | 1.14 Billion USD | 98.524% |
| NEXGEL, Inc. | 9.95 Million USD | -69.89% |
| NEXGEL, Inc. | 9.95 Million USD | -69.89% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 93.629% |
| OraSure Technologies, Inc. | 482.84 Million USD | 96.497% |
| Pro-Dex, Inc. | 54.21 Million USD | 68.802% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 72.185% |
| Predictive Oncology Inc. | 14.41 Million USD | -17.308% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.802% |
| Repligen Corporation | 2.82 Billion USD | 99.401% |
| Sanara MedTech Inc. | 73.87 Million USD | 77.105% |
| STAAR Surgical Company | 488.69 Million USD | 96.539% |
| Sharps Technology, Inc. | 11.78 Million USD | -43.457% |
| Utah Medical Products, Inc. | 135.45 Million USD | 87.515% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.771% |
| Jin Medical International Ltd. | 32.9 Million USD | 48.599% |